featured
Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation
N. Engl. J. Med 2022 Aug 28;[EPub Ahead of Print], SJ Connolly, G Karthikeyan, M Ntsekhe, A Haileamlak, A El Sayed, A El Ghamrawy, A Damasceno, A Avezum, AML Dans, B Gitura, D Hu, ER Kamanzi, F Maklady, G Fana, JA Gonzalez-Hermosillo, J Musuku, K Kazmi, L Zühlke, L Gondwe, C Ma, M Paniagua, OS Ogah, OJ Molefe-Baikai, P Lwabi, P Chillo, SK Sharma, TTJ Cabral, WM Tarhuni, A Benz, M van Eikels, A Krol, D Pattath, K Balasubramanian, S Rangarajan, C Ramasundarahettige, B Mayosi, S YusufFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.